A Study of JNJ-87801493 in Combination With T-Cell Engagers in Participants With B-cell Non-Hodgkin Lymphoid (NHLs) Cancer

计划入组 70 人 · 首次发布于 2023 年 11 月 18 日

A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies

计划入组 340 人 · 首次发布于 2025 年 12 月 29 日

CMOP±R in the Treatment of Untreated Non-Hodgkin's Lymphoma

计划入组 197 人 · 首次发布于 2024 年 7 月 3 日

5HLS

CART-NHL1

HLS-3023

NLS Pharmaceutics

Switzerland

Nils Hoyer

Germany

NHS SCOTLAND

United Kingdom

Odronextamab: Investigational Treatment for Lymphoma Awaits FDA Approval

Study Links Long-term Tattoo Exposure to Increased Risk of Rare B-Cell Lymphomas

Estrella Immunopharma's EB103 Shows Complete Response in B-Cell Lymphoma Trial